CAW
BIIB icon

Cornerstone Advisors (Washington)’s Biogen BIIB Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,427
Closed -$334K – 896
2019
Q2 		$334K Buy
1,427
+84
+6% +$19.4K 0.03% 85
2019
Q1 		$317K Buy
1,343
+238
+22% +$74.9K 0.03% 85
2018
Q4 		$333K Buy
1,105
+11
+1% +$3.51K 0.06% 70
2018
Q3 		$387K Buy
1,094
+17
+2% +$5.85K 0.25% 64
2018
Q2 		$313K Sell
1,077
-121
-10% -$34K 0.21% 73
2018
Q1 		$328K Sell
1,198
-75
-6% -$23.3K 0.22% 65
2017
Q4 		$406K Sell
1,273
-60
-5% -$19.2K 0.27% 54
2017
Q3 		$417K Sell
1,333
-106
-7% -$31.4K 0.29% 54
2017
Q2 		$390K Buy
1,439
+28
+2% +$7.4K 0.22% 51
2017
Q1 		$386K Buy
1,411
+217
+18% +$61.4K 0.21% 53
2016
Q4 		$339K Buy
1,194
+25
+2% +$7.41K 0.28% 54
2016
Q3 		$366K Buy
1,169
+887
+315% +$263K 0.31% 43
2016
Q2 		$68K Sell
282
-5
-2% -$1.32K 0.07% 130
2016
Q1 		$75K Sell
287
-41
-13% -$10.8K 0.08% 130
2015
Q4 		$100K Sell
328
-414
-56% -$119K 0.11% 122
2015
Q3 		$217K Sell
742
-164
-18% -$54.2K 0.19% 90
2015
Q2 		$366K Buy
906
+6
+0.7% +$2.41K 0.3% 54
2015
Q1 		$380K Hold
900
– – 0.29% 57
2014
Q4 		$306K Buy
900
+865
+2,471% +$280K 0.22% 73
2014
Q3 		$12K Sell
35
-5
-13% -$1.65K 0.01% 172
2014
Q2 		$13K Hold
40
– – 0.01% 183
2014
Q1 		$12K Buy
40
+10
+33% +$3.17K 0.01% 178
2013
Q4 		$8K Hold
30
– – 0.01% 157
2013
Q3 		$7K Hold
30
– – 0.01% 154
2013
Q2 		$6K Buy
+30
New +$6.41K 0.01% 113

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cornerstone Advisors (Washington)'s BIIB Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Biogen (BIIB) in Q3 2019, closing a stake of 1,427 shares — an estimated $334K sold.

Cornerstone Advisors (Washington) first reported a position in BIIB in Q2 2013 and held it in 25 quarters. The position peaked at $417K in Q3 2017. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 1,427 Biogen shares in Q3 2019, an estimated $334K.
  • Cornerstone Advisors (Washington) first reported a position in Biogen in Q2 2013 and held it in 25 quarters.
  • Cornerstone Advisors (Washington)'s Biogen position peaked at $417K in Q3 2017.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.